JWH-370

Legal status
Legal status	CA: Schedule II UK: Class B
Identifiers
IUPAC name -naphthalen-1-ylmethanone
CAS Number	914458-22-3 Y
PubChem CID	44418312
ChemSpider	23277889 Y
UNII	HJZ9JN4HNM
Chemical and physical data
Formula	C27H27NO
Molar mass	381.519 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCCCCN1C=C(C=C1C2=CC=CC=C2C)C(=O)C3=CC=CC4=CC=CC=C43
InChI InChI=1S/C27H27NO/c1-3-4-9-17-28-19-22(18-26(28)23-14-7-5-11-20(23)2)27(29)25-16-10-13-21-12-6-8-15-24(21)25/h5-8,10-16,18-19H,3-4,9,17H2,1-2H3 Y Key:HZMLAMXVETUEJZ-UHFFFAOYSA-N Y

JWH-370 (-naphthalen-1-ylmethanone) is a synthetic cannabinoid from the naphthoylpyrrole family which acts as an agonist of the CB₁ (K_i = 5.6 ± 0.4nM) and CB₂ (K_i = 4.0 ± 0.5nM) receptors, with a slight selectivity for the CB₂ receptor. JWH-370 was first synthesized in 2006 by John W. Huffman and colleagues to examine the nature of ligand binding to the CB₁ receptor.^[1]

Legality

In the United States JWH-370 is not federally scheduled, although some states have passed legislation banning the sale, possession, and manufacture of JWH-370.^[2][3][4][5]

In Canada, JWH-370 and other naphthoylpyrrole-based cannabinoids are Schedule II controlled substances under the Controlled Drugs and Substances Act.^{[citation needed]}

In the United Kingdom, JWH-370 and other naphthoylpyrrole-based cannabinoids are considered Class B drugs under the Misuse of Drugs Act 1971.^{[citation needed]}

See also

• List of JWH cannabinoids
• Synthetic cannabinoid

References

This cannabinoid related article is a stub. You can help Wikipedia by expanding it.

• v
• t
• e